CME gains after higher Q3 profit

By Reuters News

** Shares of derivatives exchange CME Group CME.O rose 0.8% to $297.71

** CME posts Q3 net income of $1.04 billion, or $2.89 per share, compared with $908 million, or $2.49 per share, a year earlier

** "As uncertainty intensified in Q3, clients turned to CME Group in record numbers to manage risk and capitalize on opportunities," said CME CEO Terry Duffy

** Reports a record Q3 average daily volume (ADV) of 29.4 million contracts, with all-time high ADVs for July and September

** Q3 revenue was up 13% to $1.73 billion

** Nine of 18 analysts rate stock "strong buy" or "buy", six "hold" and three "sell"; their median PT is $295.31 - data compiled by LSEG

** Including session's move, CME up 9% YTD

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk